Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$102.72 USD

102.72
7,656,647

-0.24 (-0.23%)

Updated Jul 16, 2024 04:00 PM ET

After-Market: $102.67 -0.05 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (157 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Here's Why You Should Add Abbott (ABT) to Your Portfolio Now

Abbott (ABT) continues to deliver strong and consistent performance in all segments. The company has also been hogging the limelight within Diabetic Care on progress with its FreeStyle Libre.

    Mark Vickery headshot

    Top Analyst Reports for Walmart, IBM & Texas Instruments

    Today's Research Daily features new research reports on 16 major stocks, including Walmart (WMT), IBM (IBM) and Texas Instruments (TXN).

      Sweta Jaiswal headshot

      Cyber Attack Fears Grip MedTech: 3 Safe Stocks

      In the wake of rising incidences of cyber attacks in the MedTech space, we have zeroed down on some stocks which at present are safe-havens for investors.

        Abbott's DRG Therapy Now Covered by Aetna, To Boost Uptake

        Abbott (ABT) to see a rise in customer adoption of its DRG therapy following the receipt of new national coverage from Aetna.

          The Zacks Analyst Blog Highlights: Abbott, Gilead, FedEx, Archer Daniels and CBRE

          The Zacks Analyst Blog Highlights: Abbott, Gilead, FedEx, Archer Daniels and CBRE

            Mark Vickery headshot

            Top Research Reports for Abbott, Gilead & FedEx

            Today's Research Daily features new research reports on 16 major stocks, including Abbott (ABT), Gilead (GILD) and FedEx (FDX).

              Edwards Lifesciences (EW) Q2 Earnings Beat, Revenues Miss

              Edwards Lifesciences (EW) gains from THVT strength on continued therapy adoption across all geographies in Q2.

                Omnicell (OMCL) Earnings & Revenues Beat Estimates in Q2

                Omnicell's (OMCL) second-quarter 2018 performance impresses with year-over-year growth in earnings and revenues.

                  Top Ranked Momentum Stocks to Buy for July 24th

                  Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 24th:

                    Agios (AGIO) Secures FDA Approval for Leukemia Drug Tibsovo

                    Agios (AGIO) gains an FDA approval for its lead pipeline candidate, Tibsovo, for the treatment of relapsed/refractory acute myeloid leukemia (AML) in patients with an IDH1 mutation.

                      Here's Why You Should Add Abbott (ABT) to Your Portfolio Now

                      We are upbeat about Abbott's (ABT) synergies from Alere buyout in the form of solid Rapid Diagnostics revenues. Emerging market performance has been promising.

                        The Zacks Analyst Blog Highlights: Wells Fargo, IBM, Abbott, Texas Instruments and Praxair

                        The Zacks Analyst Blog Highlights: Wells Fargo, IBM, Abbott, Texas Instruments and Praxair

                          Can Solid Global Prospects Drive Align's (ALGN) Q2 Earnings?

                          Align Technology (ALGN) poised to gain on continued strength in all geographies in Q2.

                            Mark Vickery headshot

                            Top Stock Reports for Wells Fargo, IBM & Abbott

                            Today's Research Daily features new research reports on 16 major stocks, including Wells Fargo (WFC), IBM (IBM) and Abbott (ABT).

                              Abbott (ABT) Q2 Earnings & Revenues Top Estimates, View Up

                              Abbott (ABT) posts another quarter of strong EPD and Medical Devices performance. Particularly, Abbott has been riding high on a healthy growth within its Diabetes Care business.

                                Mark Vickery headshot

                                Housing Starts/Permits Disappoint; MS, USB and ABT Beat

                                Morgan Stanley, U.S. Bank and Abbott all beat expectations, but new Housing Starts and Permits numbers were far below expectations.

                                  Abbott (ABT) Beats on Earnings and Revenues in Q2

                                  Abbott (ABT) gains ground on new product launches and solid overall growth and delivers strong Q2 results.

                                    Tracey Ryniec headshot

                                    These Companies are Earnings All-Stars

                                    It's not easy to beat on earnings nearly every quarter but these 5 companies are doing just that. Can they keep up their winning streaks?

                                      Can Established Pharmaceuticals Up Abbott (ABT) Q2 Earnings?

                                      According to Abbott (ABT), key emerging markets represent the most attractive long-term growth opportunities for its branded generics product portfolio within EPD.

                                        Can Medical Devices Strength Drive Abbott (ABT) Q2 Earnings?

                                        Abbott (ABT) poised to gain on continued growth in Medical Devices business in Q2.

                                          Can Abbott (ABT) Rise on Robust Overall Growth in Q2 Earnings?

                                          Abbott (ABT) gains traction from a steady healthy growth trajectory seen in core Diabetes Care business.

                                            Here's Why AbbVie Stock is Good for Your Portfolio's Health

                                            Here are six reasons why investing in AbbVie (ABBV) stock is a good decision now.

                                              The Zacks Analyst Blog Highlights: Facebook, Amgen, Abbott, Coca-Cola and 3M

                                              The Zacks Analyst Blog Highlights: Facebook, Amgen, Abbott, Coca-Cola and 3M

                                                Mark Vickery headshot

                                                Top Stock Reports for Facebook, Amgen & Abbott

                                                Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), Amgen (AMGN), and Abbott (ABT).

                                                  Sweta Jaiswal headshot

                                                  Tap Cardiovascular Devices Market Boom With These 3 Stocks

                                                  Consider these three stocks in the rapidly-growing cardiovascular devices market.